Although this study observed higher DJ1 levels in EC patients ( n = 45) compared to healthy controls ( n = 29, p < 0.0001), the differences in serum levels between patients with an early stage (FIGO I, II; n = 38) or advanced disease (FIGO III, IV; n = 7) failed to reach statistical significance ( p = 0.86) [ 16 ].
← all excerpts
The Clinical Significance of DJ1 and L1CAM Serum Level Monitoring in Patients with Endometrial Cancer.
1
0.8600
0.8600